Tables: Buyers
| Sellers
THE SLUMPING REAL-ESTATE MARKET has hurt
CB
Richard Ellis Group, but one hedge fund has moved in on
the beaten-down shares, buying more than 13 million since the
beginning of the year.
On Thursday Lone Pine Capital disclosed a 6.6%
stake, or 13,244,686 shares of the commercial real-estate company.
Lone Pine did not show any ownership in CB Richard Ellis as of Dec.
31, 2007, but it now stands as the company's fourth-largest
holder.
Lone Pine reported the purchases to the Securities
and Exchange Commission as a passive investor. The firm indicated
that it reached the ownership threshold that triggered the filing on
March 10.
Lone Pine was founded in 1997 by Steve Mandel, the
former managing director and consumer analyst at Tiger Management.
Today Lone Pine has $9 billion under its management.
Greenwich, Conn.-based Lone Pine could not be
reached for comment.
A spokesman for CB Richard Ellis declined to
comment on the purchases.
"This is yet another sign that longer term savvy
insiders are starting to bet in this beaten-down sector," says
Jonathan Moreland, adviser to Ladenburg Thalmann Asset Management on
insider strategies.
"There has been impressive strength of the
financial sector as of late, including real-estate investment trusts
(REITs), real estate and banks, and insider buying for a number of
quarters now, so it's just been a case of waiting for the technicals
to firm up, and there have been impressive technical moves in the
past week," he says.
Fears about the slowing commercial real-estate
market have taken their toll on Los Angeles-based CB Richard Ellis.
Its stock is down more than 38% in the past year, and its 52-week
intraday low of $15.23, reached on Jan. 22, is less than half the
high of $42.74 it traded at in July 2007.
On Tuesday shares lost 23 cents to $21.81.
However, Moreland believes that there is more cause
for optimism in the current environment.
"With Mandel you have yet another successful
institutional investor who thinks the bottom is in and riding on his
coattails doesn't seem like a bad idea, if you have the same
longer-term time frame that he does," he says. "CB Richard Ellis has
recovered nicely from its lows [in January]. And the financials have
taken off so quickly this week: This is the price action I've been
looking for to help confirm a bottom may be in. Things can't go
straight up from here, but…it could be a good time to phase [into] a
position."
Analysts surveyed by Thomson Financial are also
bullish about CB Richard Ellis' prospects. On average they rated the
company a Buy or the equivalent, with a 12-month target price of
$23.
The purchases by Lone Pine came as William Blair
analyst Brandon Dobell was traveling with CB Richard Ellis
management, and he came to a similar conclusion.
"For those investors with a long-term investment
horizon (18 months or more) and a willingness to endure near-term
volatility, the current valuation provides a solid entry point, with
downside in our view probably to the $13-$15 range at most," he
wrote in a research note on March 10.
Dobell has a Market Perform rating on CB Richard
Ellis.
Still, other institutional investors aren't as
confident as Lone Pine. According to Joshua Hong, director of
research at OwnershipAnalyzer.com, CB Richard Ellis saw a "huge
turnover" of nearly 60% as institutions decreased their
positions.
However, CB Richard Ellis's top holder FMR Corp. --
the parent company of financial-services giant Fidelity --
substantially raised its position, from 14.8 million shares at the
end of the third quarter of 2007 to more than 32 million shares.
"It could be a good investment for the long term,"
Hong wrote in an e-mail. But he notes that "CB Richard Ellis would
be mostly dependent on the sector turnaround, which is very hard to
predict."
Recent Insider Activity
BUYERS:
| COMPANY NAME |
INSIDERS NAME |
TITLE |
$ VALUE |
NO. OF SHARES IN TRANS. |
RANGE OF VALUES |
TRANSACTIONS DATES |
| Halozyme
Therapeutics |
R. Kirk |
DO |
$7,704,901 |
1,264,657 |
6.06-6.12 |
March 20, 2008 |
| Pure
Cycle |
A. Epker |
D |
2,431,336 |
449,799 |
5.18-5.50 |
Mar 19-20, 2008 |
| Akorn
|
J. Kapoor |
DO |
186,884 |
40,000 |
4.67 |
March 20, 2008 |
| EuroBancshares
|
P. Feliciano Benitez |
D |
150,000 |
30,000 |
5 |
March 20, 2008 |
| Ceco
Environmental |
P. Dezwirek |
CEO |
135,600 |
20,000 |
6.75-6.80 |
March 20, 2008 |
| Emeritus
|
S. Baty |
DO |
110,916 |
5,000 |
22.13-22.22 |
March 20, 2008 |
| EuroBancshares
|
J. Rodriguez |
D |
100,000 |
20,000 |
5 |
March 20, 2008 |
| Citizens
First Bancorp |
M. Campbell |
CEO |
98,556 |
10,000 |
9.86 |
March 24, 2008 |
| EV
Energy Partners |
G. Lindahl |
D |
93,598 |
4,000 |
23.35-23.50 |
March 24, 2008 |
| EuroBancshares
|
W. Torres |
D |
75,000 |
15,000 |
5 |
March 20, 2008 |
(Source: Thomson Financial/Baseline)
SELLERS:
| COMPANY NAME |
INSIDERS NAME |
TITLE |
$ VALUE |
NO. OF SHARES IN TRANS. |
RANGE OF VALUES |
TRANSACTIONS DATES |
| Lifecore
Biomedical |
J. Runnells |
D |
$14,302,100 |
841,300 |
17 |
March 20, 2008 |
| Hess
|
H. Paver |
O |
7,290,000 |
81,000 |
90 |
March 20, 2008 |
| Hess
|
L. Ornstein |
O |
4,651,957 |
51,792 |
89.82 |
March 20, 2008 |
| Hess
|
J. Scelfo |
O |
3,353,245 |
37,488 |
89.25-89.95 |
March 20, 2008 |
| FedEx
|
A. Graf |
CFO |
2,636,038 |
29,183 |
90.16-90.49 |
March 24, 2008 |
| Urban
Outfitters |
J. Kyees |
CFO |
2,294,653 |
75,000 |
30.53-30.67 |
March 20, 2008 |
| FedEx
|
A. Graf |
CFO |
1,879,129 |
20,817 |
90.15-90.52 |
March 24, 2008 |
| Vornado
Realty Trust |
R. Smith |
OD |
1,723,174 |
20,000 |
86.16 |
March 20, 2008 |
| Applied
Industrial Technologies |
D. Pugh |
CEO |
1,677,369 |
55,900 |
30-30.015 |
March 20, 2008 |
| Halozyme
Therapeutics |
J. Lim |
CEO |
1,515,000 |
250,000 |
6.06 |
March 20, 2008 |
(Source: Thomson Financial/Baseline)
Here's a rundown of insider trading activity reported
on March 25, 2008. An insider is any officer, director or owner of
10% or more of a class of the company's securities. The table shows
purchases and sales which must be reported to the SEC and other
regulators by the 10th of the month following the month of the
trade, includes both open-market and private transactions involving
direct and indirect holdings. Excludes stock valued at less that $2
per share, acquisitions through options and companies being
acquired. Included are purchases, sales and stock registered for
sale for individual officers, companies, and sectors.
AC-member of the advisory committee. AF-affiliated
person. AI-affiliate of investment advisor. AV-assistant vice
president. B-beneficial owner of more than 10% of a security class.
BC-beneficial owner as custodian. BT-beneficial owner as trustee.
C-controller. CB-chairman. CC-member of the compensation committee.
CEO-chief executive officer. CFO-chief financial officer. CI-chief
investment officer. CO-chief operating officer. CP-controlling
person. CT-chief technology officer. D-director. DO-director and
beneficial owner. DS-indirect shareholder. EC-member of the
executive committee. EVP-executive vice president. F-founder.
FC-member of the finance committee. FO-former. GC-general counsel.
GM-general manager. GP-general partner. H-officer, director and
beneficial owner. I-indirect transaction filed through a trust,
insider spouse, minor child or other. IA-investment advisor.
LP-limited partner. M-managing partner. MC-member of committee or
advisory board. MD-managing director. O-officer. OB-officer and
beneficial owner. OD-officer and director. OE-other executive.
OP-officer of parent company. OS-officer of subsidiary company.
OT-officer and treasurer. OX-divisional officer. P-president.
R-retired. S-secretary. SC-member of the science/technology
committee. SH-shareholder. SVP-senior vice president. T-trustee.
TR-treasurer. UT-unknown. VC-vice chairman. VP-vice president.
VT-voting trustee. X-deceased.
*-Half of the transactions were indirect.